Status:
UNKNOWN
The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The Australian government swift interventions and actions early to the COVID 19 epidemic included enforced quarantine, isolation, varying degrees of social and physical distancing measures, travel res...
Detailed Description
This is a mixed methods longitudinal study of a cohort of 1000 participants for a 18 month period. Victorian adults from three key risk populations will be recruited into two longitudinal cohort group...
Eligibility Criteria
Inclusion
- Community participants
Exclusion
- Unable to provide consent
Key Trial Info
Start Date :
September 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05323799
Start Date
September 30 2020
End Date
June 30 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Macfarlane Burnet Institute for Medical Research and Public Health
Melbourne, Victoria, Australia, 3004